Does ROSUVASTATIN Cause Haemoglobin decreased? 241 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 241 reports of Haemoglobin decreased have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.7% of all adverse event reports for ROSUVASTATIN.
241
Reports of Haemoglobin decreased with ROSUVASTATIN
0.7%
of all ROSUVASTATIN reports
7
Deaths
99
Hospitalizations
How Dangerous Is Haemoglobin decreased From ROSUVASTATIN?
Of the 241 reports, 7 (2.9%) resulted in death, 99 (41.1%) required hospitalization, and 17 (7.1%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 241 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which ROSUVASTATIN Alternatives Have Lower Haemoglobin decreased Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN